Chimerix (NASDAQ: CMRX) reported Q2 EPS of ($0.39), $0.05 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $919 thousand versus the consensus estimate of $740 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.